Peptide therapy: what the evidence actually says

Peptides are short amino acid chains that act as targeted signalling molecules. Because they instruct specific receptors rather than broadly replacing a hormone, they can produce precise effects at very small doses.

The evidence base is uneven. Tesamorelin has genuine clinical trial data for visceral fat reduction. BPC-157 has substantial animal data and considerable clinical experience but limited large human trials.

Regulatory status shifts. Some peptides are FDA-approved for specific indications, others are prescribed off-label, and what compounding pharmacies may lawfully prepare changes over time.

We only dispense what a licensed US compounding pharmacy can lawfully prepare against a valid prescription. We do not supply research-only material, and you should be wary of anyone who does.

Most protocols are cycled rather than run continuously, both to maintain receptor sensitivity and to create natural review points where a provider can assess whether the therapy is still earning its place.